Esteban Celis

GRA/Whitaker Eminent Scholar in Cancer

Esteban Celis

GRA/Whitaker Eminent Scholar in Cancer

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Medicine: Oncology Research

Medical College of Georgia
Department of Medicine: Hematology and Oncology

Medical College of Georgia
Department of Georgia Cancer Center

Medical College of Georgia
Department of Neuroscience and Regenerative Medicine

Medical College of Georgia
Department of Biochemistry and Molecular Biology

The Graduate School

Other Duties

GRA/Whitaker Eminent Scholar in Cancer

Bio

Dr. Celis received his MD, MSc, and PhD degrees from the National University of Mexico. He was a Fogarty International Fellow at the Center for Cancer Research at Massachusetts Institute of Technology.

Education

  • Ph.D., Biomedical Sciences, General Ntnl Autonomous Univ of Mexico, 1981

  • MD, Medicine Ntnl Autonomous Univ of Mexico, 1977

  • MS, Biomedical Sciences, General Ntnl Autonomous Univ of Mexico, 1976

Awards & Honors

  • Outstanding Investigator Awards 2015

  • Invited Guest Lecturer Award 2013

Courses Taught Most Recent Academic Year

  • BIOM 8215

    Fundamentals of Oncology I

Teaching Interests

Immunology, Tummor immunology

Scholarship

Selected Recent Publications

  • ). Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model., 2019
    Journal Article, Academic Journal
  • PD-L1-specific helper T cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma, 2019
    Journal Article, Academic Journal
  • The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice. , 2019
    Journal Article, Academic Journal
  • CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma, 2015
    Journal Article, Academic Journal
  • Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells, 2015
    Journal Article, Academic Journal

Research Interests

Tumor Immunology, Vaccines